研究目的
Investigating the use of novel disposable optical biochips based on one-dimensional photonic crystals (1DPC) sustaining Bloch surface waves (BSW) for the detection of cancer biomarkers, specifically the ERBB2 breast cancer biomarker, and addressing the challenge of photobleaching in biosensing assays.
研究成果
The study presents a novel approach to model anisotropic fluorescence emission and manage photobleaching effects in biosensing assays using 1DPC biochips, leading to correct interpretation of the assays. It emphasizes the importance of addressing photobleaching for accurate and quantitative information in cancer biomarker detection.
研究不足
The study highlights the lack of research on photobleaching in experiments with BSW sustained by 1DPC, which affects the trustworthiness of the output in biosensing assays, especially close to the limit of detection (LoD).
1:Experimental Design and Method Selection:
The study utilizes a biosensing platform based on 1DPC biochips capable of working in both label-free and fluorescence detection modes. The label-free configuration employs a prism coupling system for BSW excitation, while the fluorescence mode uses dye labeled antibodies bound at the 1DPC surface.
2:Sample Selection and Data Sources:
The study focuses on detecting the ERBB2 breast cancer biomarker in biological complex matrices and cell lysate samples.
3:List of Experimental Equipment and Materials:
The platform includes 1DPC biochips and a reading instrument.
4:Experimental Procedures and Operational Workflow:
The label-free mode involves BSW excitation via a prism coupling system, and the fluorescence mode involves coupling between dye labels and BSW for directional fluorescence emission.
5:Data Analysis Methods:
A theoretical model is used to interpret the experimental data, considering the orientational distribution of dye labels, density of optical states of the 1DPC, photobleaching, and rotational diffusion of surface bound emitters.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容